Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-027854
Filing Date
2009-02-13
Accepted
2009-02-13 06:05:41
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1245499
2 SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT dex104.htm EX-10.4 46374
3 FORM OF EXECUTIVE SEVERANCE BENEFITS AGREEMENT dex108.htm EX-10.8 41268
4 SUMMARY OF NON-EMPLOYEE DIRECTOR COMPENSATION dex1039.htm EX-10.39 1233
5 LIST OF SUBSIDIARIES dex211.htm EX-21.1 718
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1602
7 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 9188
8 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 9206
9 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 4573
  Complete submission text file 0001193125-09-027854.txt   1361179
Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100
Monogram Biosciences, Inc. (Filer) CIK: 0001094961 (see all company filings)

EIN.: 943234479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30369 | Film No.: 09597529
SIC: 2835 In Vitro & In Vivo Diagnostic Substances